RSS
» Read the rest of this entry
Comments Off on Putin prepares for long-term war of attrition Defence Intelligence
» Read the rest of this entry
Comments Off on Medvedchuk writes article about Ukraine, threatening that war will spread to other European countries

Advisers warn of pain to come as a poll for the BBC suggests many have no idea how they will repay festive spending.

» Read the rest of this entry
Comments Off on Cost of living: Charity warns Christmas debt could take years to repay

Shareholders are voting on the future of the company which aims to make batteries for electric cars.

» Read the rest of this entry
Comments Off on Britishvolt: Fears rise over future of British battery giant
16 Jan 2023

Dr Ranj Singh: Four ways to protect your mental health

Author: admintech | Filed under: Business

The rising cost of living can be stressful but there are steps you can take to help.

» Read the rest of this entry
Comments Off on Dr Ranj Singh: Four ways to protect your mental health
16 Jan 2023

Energy boss warns higher bills are here to stay

Author: admintech | Filed under: Business

Equinor’s chief says while prices will not be as volatile, investment in renewables must be paid for.

» Read the rest of this entry
Comments Off on Energy boss warns higher bills are here to stay

The Early Launch comes with the first Season Pass and many new content Countless new and unique skins to show off your taste SINGAPORE, Jan. 15, 2023 /PRNewswire/ — Closing […]

» Read the rest of this entry
Comments Off on Aiming For “The Best Casual Game 2023”, Thetan Rivals Introduces A New Map, New Game Mode, And New Skins

SAN FRANCISCO, Jan. 15, 2023 /PRNewswire/ — Inflect, Inc., the world’s leading marketplace for buyers and sellers of digital infrastructure, today announced the launch of advanced quoting capabilities in its […]

» Read the rest of this entry
Comments Off on Inflect Introduces Advanced Quoting Capabilities to its Portal and announces new Partner Program

Rykindo® is a bi-weekly long-acting risperidone injection and is the first innovative therapy from Luye Pharma’s Central Nervous System (CNS) product portfolio to be marketed in the United States. PRINCETON, […]

» Read the rest of this entry
Comments Off on FDA Approves Luye Pharma’s Rykindo® for the Treatment of Schizophrenia and Bipolar 1 Disorder

TEL AVIV, Israel, Jan. 15, 2023 /PRNewswire/ — Cipia (TASE: CPIA), an AI computer vision in-cabin automotive solutions provider, today announced that the company had secured a design win with […]

» Read the rest of this entry
Comments Off on Cipia announces new design win; additional OEM to integrate Driver Sense DMS